A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

NCT00355355 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular
Liver Neoplasms

Interventions

DRUG: Talaporfin sodium
DEVICE: Interstitial Light Emitting Diodes
PROCEDURE: Percutaneous placement of device in the liver
PROCEDURE: Standard Care

Sponsor

Light Sciences Oncology